PATENT CLAIM ANALYSIS

Application Number: 16109337
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["544", "262000"]

Abstract:
The present invention relates to selective inhibitors of PI3K delta protein kinases, methods of preparing them, pharmaceutical compositions containing them and methods of treatment and/or prevention of kinase mediated diseases or disorders with them.

Claim (Index 27):
The method of  claim 24 , wherein the leukemia is selected from acute leukemia, acute lymphocytic leukemia, acute lymphoblastic leukemia, acute myelocytic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, myelodysplastic syndrome, promyelocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, chronic granulocytic leukemia, hairy-cell leukemia and erythroleukemia.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 96.0
- Lexical Diversity: 1.23333
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15283515', '13933856', '15480128', '14832962', '14440139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8398694799403835
- 35 USC 102 Novelty (BERT): 0.6053551957773831
- Combined Prediction Score: 0.8164180515240834
- Mean Citation Score: 544.4503659999998
- Max Citation Score: 583.6667
- Similarity Product: 457.8355267847776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test